{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:55:01Z","timestamp":1787500501849,"version":"build-2736575974"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1177\/1933719117750751","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T02:09:12Z","timestamp":1515722952000},"page":"802-817","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Therapeutic Roles of Statins in Gynecology and Obstetrics: The Current Evidence"],"prefix":"10.1007","volume":"25","author":[{"given":"Burak","family":"Zeybek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maged","family":"Costantine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokhan S.","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0554-132X","authenticated-orcid":false,"given":"Mostafa A.","family":"Borahay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,1]]},"reference":[{"issue":"6257","key":"2506802_CR1","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/343425a0","volume":"343","author":"JL Goldstein","year":"1990","unstructured":"Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature. 1990;343(6257):425\u2013430.","journal-title":"Nature"},{"issue":"4","key":"2506802_CR2","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1210\/jcem.87.4.8412","volume":"87","author":"SI McFarlane","year":"2002","unstructured":"McFarlane SI, Muniyappa R, Francisco R, Sowers JR. Clinical review 145: pleiotropic effects of statins: lipid reduction and beyond. J Clin Endocrinol Metab. 2002;87(4):1451\u20131458.","journal-title":"J Clin Endocrinol Metab"},{"issue":"18","key":"2506802_CR3","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1101\/gad.11.18.2295","volume":"11","author":"L Van Aelst","year":"1997","unstructured":"Van Aelst L, D\u2019Souza-Schorey C. Rho GTPases and signaling networks. Genes Dev. 1997;11(18):2295\u20132322.","journal-title":"Genes Dev"},{"issue":"9447","key":"2506802_CR4","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(04)17403-5","volume":"364","author":"LC Giudice","year":"2004","unstructured":"Giudice LC, Kao LC. Endometriosis. Lancet. 2004;364(9447): 1789\u20131799.","journal-title":"Lancet"},{"issue":"1","key":"2506802_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ejogrb.2010.10.026","volume":"155","author":"M Adachi","year":"2011","unstructured":"Adachi M, Nasu K, Tsuno A, Yuge A, Kawano Y, Narahara H. Attachment to extracellular matrices is enhanced in human endometriotic stromal cells: a possible mechanism underlying the pathogenesis of endometriosis. Eur J Obstet Gynecol Reprod Biol. 2011;155(1):85\u201388.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"2506802_CR6","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.fertnstert.2007.05.051","volume":"89","author":"A Hasegawa","year":"2008","unstructured":"Hasegawa A, Yoshino O, Osuga Y, Hirata T, Yano T, Taketani Y. High soluble CD44 concentration in peritoneal fluid in endometriosis. Fertil Steril. 2008;89(5):1267\u20131268.","journal-title":"Fertil Steril"},{"issue":"6","key":"2506802_CR7","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/j.fertnstert.2008.12.012","volume":"93","author":"JS Griffith","year":"2010","unstructured":"Griffith JS, Liu YG, Tekmal RR, Binkley PA, Holden AE, Schenken RS. Menstrual endometrial cells from women with endometriosis demonstrate increased adherence to peritoneal cells and increased expression of CD44 splice variants. Fertil Steril. 2010;93(6):1745\u20131749.","journal-title":"Fertil Steril"},{"issue":"3","key":"2506802_CR8","first-page":"207","volume":"52","author":"HO Kim","year":"2007","unstructured":"Kim HO, Yang KM, Kang IS, et al. Expression of CD44s, vascular endothelial growth factor, matrix metalloproteinase- 2 and Ki-67 in peritoneal, rectovaginal and ovarian endometriosis. J Reprod Med. 2007;52(3):207\u2013213. Zeybek et al 813","journal-title":"J Reprod Med"},{"issue":"1","key":"2506802_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1095\/biolreprod.111.098806","volume":"87","author":"A Sokalska","year":"2012","unstructured":"Sokalska A, Cress A, Bruner-Tran KL, et al. Simvastatin decreases invasiveness of human endometrial stromal cells. Biol Reprod. 2012;87(1):1\u20136.","journal-title":"Biol Reprod"},{"issue":"6","key":"2506802_CR10","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1016\/j.fertnstert.2009.06.055","volume":"92","author":"K Nasu","year":"2009","unstructured":"Nasu K, Yuge A, Tsuno A, Narahara H. Simvastatin inhibits the proliferation and the contractility of human endometriotic stromal cells: a promising agent for the treatment of endometriosis. Fertil Steril. 2009;92(6):2097\u20132099.","journal-title":"Fertil Steril"},{"issue":"2","key":"2506802_CR11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.rbmo.2009.11.004","volume":"20","author":"B Yilmaz","year":"2010","unstructured":"Yilmaz B, Ozat M, Kilic S, et al. Atorvastatin causes regression of endometriotic implants in a rat model. Reprod Biomed Online. 2010;20(2):291\u2013299.","journal-title":"Reprod Biomed Online"},{"issue":"7","key":"2506802_CR12","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1210\/jc.2010-0072","volume":"95","author":"A Sokalska","year":"2010","unstructured":"Sokalska A, Wong DH, Cress A, et al. Simvastatin induces apoptosis and alters cytoskeleton in endometrial stromal cells. J Clin Endocrinol Metab. 2010;95(7):3453\u20133459.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3-4","key":"2506802_CR13","first-page":"41","volume":"136","author":"J Rutishauser","year":"2006","unstructured":"Rutishauser J. The role of statins in clinical medicine\u2013LDL\u2013cholesterol lowering and beyond. Swiss Med Wkly. 2006;136(3-4): 41\u201349.","journal-title":"Swiss Med Wkly"},{"issue":"6","key":"2506802_CR14","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1161\/hc0602.103393","volume":"105","author":"M Weis","year":"2002","unstructured":"Weis M, Heeschen C, Glassford AJ, Cooke JP. Statins have biphasic effects on angiogenesis. Circulation. 2002;105(6):739\u2013745.","journal-title":"Circulation"},{"issue":"5","key":"2506802_CR15","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1093\/humrep\/del505","volume":"22","author":"M Oktem","year":"2007","unstructured":"Oktem M, Esinler I, Eroglu D, Haberal N, Bayraktar N, Zeyneloglu HB. High-dose atorvastatin causes regression of endometriotic implants: a rat model. Hum Reprod. 2007;22(5): 1474\u20131480.","journal-title":"Hum Reprod"},{"issue":"2","key":"2506802_CR16","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.fertnstert.2006.06.040","volume":"87","author":"N Esfandiari","year":"2007","unstructured":"Esfandiari N, Khazaei M, Ai J, et al. Effect of a statin on an in vitro model of endometriosis. Fertil Steril. 2007;87(2):257\u2013262.","journal-title":"Fertil Steril"},{"issue":"5","key":"2506802_CR17","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.fertnstert.2009.10.003","volume":"94","author":"I Sharma","year":"2010","unstructured":"Sharma I, Dhawan V, Mahajan N, Saha SC, Dhaliwal LK. In vitro effects of atorvastatin on lipopolysaccharide-induced gene expression in endometriotic stromal cells. Fertil Steril. 2010; 94(5):1639\u20131646.","journal-title":"Fertil Steril"},{"issue":"1","key":"2506802_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/biolre\/iox058","volume":"97","author":"HS Taylor","year":"2017","unstructured":"Taylor HS, Alderman III M, D\u2019Hooghe TM, Fazleabas AT, Duleba AJ. Effect of simvastatin on baboon endometriosis. Biol Reprod. 2017;97(1):32\u201338.","journal-title":"Biol Reprod"},{"issue":"6","key":"2506802_CR19","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1177\/1933719111430998","volume":"19","author":"H Cakmak","year":"2012","unstructured":"Cakmak H, Basar M, Seval-Celik Y, et al. Statins inhibit monocyte chemotactic protein 1 expression in endometriosis. Reprod Sci. 2012;19(6):572\u2013579.","journal-title":"Reprod Sci"},{"issue":"5","key":"2506802_CR20","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00404-014-3295-4","volume":"290","author":"Y Simsek","year":"2014","unstructured":"Simsek Y, Gul M, Yilmaz E, Ozerol IH, Ozerol E, Parlakpinar H. Atorvastatin exerts anti-nociceptive activity and decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-a in a rat endometriosis model. Arch Gynecol Obstet. 2014; 290(5):999\u20131006.","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"2506802_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1095\/biolreprod.106.051763","volume":"75","author":"PC Piotrowski","year":"2006","unstructured":"Piotrowski PC, Kwintkiewicz J, Rzepczynska IJ, et al. Statins inhibit growth of human endometrial stromal cells independently of cholesterol availability. Biol Reprod. 2006;75(1): 107\u2013111.","journal-title":"Biol Reprod"},{"key":"2506802_CR22","doi-asserted-by":"publisher","first-page":"534","DOI":"10.12659\/MSM.883967","volume":"19","author":"F Almassinokiani","year":"2013","unstructured":"Almassinokiani F, Mehdizadeh A, Sariri E, et al. Effects of simvastatin in prevention of pain recurrences after surgery for endometriosis. Med Sci Monit. 2013;19:534\u2013539.","journal-title":"Med Sci Monit"},{"issue":"5","key":"2506802_CR23","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1210\/jc.2008-2093","volume":"94","author":"AV Hoekstra","year":"2009","unstructured":"Hoekstra AV, Sefton EC, Berry E, et al. Progestins activate the AKT pathway in leiomyoma cells and promote survival. J Clin Endocrinol Metab. 2009;94(5):1768\u20131774.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2506802_CR24","volume":"9","year":"2014","unstructured":"Murtola TJ, Visvanathan K, Artama M, Vainio H, Pukkala E. Statin use and breast cancer survival: a nationwide cohort study from Finland. PLoS One. 2014;9(10):e110231.","journal-title":"PLoS One"},{"issue":"3","key":"2506802_CR25","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.ygyno.2014.04.007","volume":"133","author":"Y Liu","year":"2014","unstructured":"Liu Y, Qin A, Li T, Qin X, Li S. Effect of statin on risk of gynecologic cancers: a meta-analysis of observational studies and randomized controlled trials. Gynecol Oncol. 2014;133(3): 647\u2013655.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"2506802_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1158\/1055-9965.EPI-07-0531","volume":"17","author":"A Hoque","year":"2008","unstructured":"Hoque A, Chen H, Xu XC. Statin induces apoptosis and cell growth arrest in prostate cancer cells. Cancer Epidemiol Biomarkers Prev. 2008;17(1):88\u201394.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"2506802_CR27","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/ijc.23593","volume":"123","author":"SJ Cho","year":"2008","unstructured":"Cho SJ, Kim JS, Kim JM, Lee JY, Jung HC, Song IS. Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice. Int J Cancer. 2008;123(4):951\u2013957.","journal-title":"Int J Cancer"},{"issue":"9","key":"2506802_CR28","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S0301-472X(03)00192-9","volume":"31","author":"D Chapman-Shimshoni","year":"2003","unstructured":"Chapman-Shimshoni D, Yuklea M, Radnay J, Shapiro H, Lishner M. Simvastatin induces apoptosis of B-CLL cells by activation of mitochondrial caspase 9. Exp Hematol. 2003;31(9):779\u2013783.","journal-title":"Exp Hematol"},{"issue":"51","key":"2506802_CR29","doi-asserted-by":"publisher","first-page":"35075","DOI":"10.1074\/jbc.M114.583575","volume":"289","author":"MA Borahay","year":"2014","unstructured":"Borahay MA, Kilic GS, Yallampalli C, et al. Simvastatin potently induces calcium-dependent apoptosis of human leiomyoma cells. J Biol Chem. 2014;289(51):35075\u201335086.","journal-title":"J Biol Chem"},{"issue":"1","key":"2506802_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1677\/joe.0.1720083","volume":"172","author":"KD Burroughs","year":"2002","unstructured":"Burroughs KD, Howe SR, Okubo Y, Fuchs-Young R, LeRoith D, Walker CL. Dysregulation of IGF-I signaling in uterine leiomyoma. J. Endocrinol. 2002;172(1):83\u201393.","journal-title":"J. Endocrinol"},{"issue":"6","key":"2506802_CR31","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1016\/j.fertnstert.2007.10.083","volume":"91","author":"L Peng","year":"2009","unstructured":"Peng L, Wen Y, Han Y, et al. Expression of insulin-like growth factors (IGFs) and IGF signaling: molecular complexity in uterine leiomyomas. Fertil Steril. 2009;91(6):2664\u20132675.","journal-title":"Fertil Steril"},{"issue":"1","key":"2506802_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0015-0282(02)03154-0","volume":"78","author":"I Sozen","year":"2002","unstructured":"Sozen I, Arici A. Interactions of cytokines, growth factors, and the extracellular matrix in the cellular biology of uterine leiomyomata. Ferti Steril. 2002;78(1):1\u201312.","journal-title":"Ferti Steril"},{"issue":"3","key":"2506802_CR33","first-page":"1716","volume":"130","author":"MJ Rossi","year":"1992","unstructured":"Rossi MJ, Chegini N, Masterson BJ. Presence of epidermal growth factor, platelet-derived growth factor, and their receptors in human myometrial tissue and smooth muscle cells: their action in smooth muscle cells in vitro. Endocrinology. 1992;130(3): 1716\u20131727.","journal-title":"Endocrinology"},{"issue":"2","key":"2506802_CR34","volume":"213","year":"2015","unstructured":"Borahay MA, Vincent K, Motamedi M, et al. Novel effects of simvastatin on uterine fibroid tumors: in vitro and patient-derived xenograft mouse model study. Am J Obstet Gynecol. 2015;213(2): 196.e1-e8.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"2506802_CR35","volume":"215","year":"2016","unstructured":"Borahay MA, Fang X, Baillargeon JG, Kilic GS, Boehning DF, Kuo YF. Statin use and uterine fibroid risk in hyperlipidemia patients: a nested case-control study. Am J Obstet Gynecol. 2016;215(6):750.e1-750.e8.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2506802_CR36","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1093\/humrep\/dep399","volume":"25","author":"WA March","year":"2010","unstructured":"March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25(2):544\u2013551.","journal-title":"Hum Reprod"},{"issue":"4","key":"2506802_CR37","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrendo.2010.217","volume":"7","author":"MO Goodarzi","year":"2011","unstructured":"Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011;7(4):219\u2013231.","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"2506802_CR38","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1210\/endo-124-5-2297","volume":"124","author":"H Engelhardt","year":"1989","unstructured":"Engelhardt H, Gore-Langton RE, Armstrong DT. Mevinolin (lovastatin) inhibits androstenedione production by porcine ovarian theca cells at the level of the 17 alpha-hydroxylase: C-17,20- lyase complex. Endocrinology. 1989;124(5):2297\u20132304.","journal-title":"Endocrinology"},{"issue":"suppl3","key":"2506802_CR39","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.fertnstert.2004.03.037","volume":"82","author":"D Izquierdo","year":"2004","unstructured":"Izquierdo D, Foyouzi N, Kwintkiewicz J, Duleba AJ. Mevastatin inhibits ovarian theca-interstitial cell proliferation and steroidogenesis. Fertil Steril. 2004;82(suppl 3):1193\u20131197.","journal-title":"Fertil Steril"},{"issue":"1","key":"2506802_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1095\/biolreprod.111.094714","volume":"86","author":"I Ortega","year":"2012","unstructured":"Ortega I, Cress AB, Wong DH, et al. Simvastatin reduces steroidogenesis by inhibiting Cyp17a1 gene expression in rat ovarian theca-interstitial cells. Biol Reprod. 2012;86(1):1\u20139.","journal-title":"Biol Reprod"},{"issue":"5","key":"2506802_CR41","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1095\/biolreprod.109.078667","volume":"81","author":"IJ Rzepczynska","year":"2009","unstructured":"Rzepczynska IJ, Piotrowski PC, Wong DH, Cress AB, Villanueva J, Duleba AJ. Role of isoprenylation in simvastatin-induced inhibition of ovarian theca-interstitial growth in the rat. Biol Reprod. 2009;81(5):850\u2013855.","journal-title":"Biol Reprod"},{"key":"2506802_CR42","volume-title":"Cochrane Database Syst Rev","author":"AD Raval","year":"2011","unstructured":"Raval AD, Hunter T, Stuckey B, Hart RJ. Statins for women with polycystic ovary syndrome not actively trying to conceive. Cochrane Database Syst Rev. 2011;(10):CD008565."},{"issue":"6","key":"2506802_CR43","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1055\/s-0032-1304619","volume":"120","author":"L Gao","year":"2012","unstructured":"Gao L, Zhao FL, Li SC. Statin is a reasonable treatment option for patients with polycystic ovary syndrome: a meta-analysis of randomized controlled trials. Exp Clin Endocrinol Diabetes. 2012; 120(6):367\u2013375.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"3","key":"2506802_CR44","volume":"5","year":"2015","unstructured":"Sun J, Yuan Y, Cai R, et al. An investigation into the therapeutic effects of statins with metformin on polycystic ovary syndrome: a meta-analysis of randomized controlled trials. BMJ Open. 2015; 5(3):e007280.","journal-title":"BMJ Open"},{"key":"2506802_CR45","first-page":"269","volume-title":"Pharm Pharmacol Commun","author":"HN Joshi","year":"1999","unstructured":"Joshi HN, Fakes MG, Serajuddin ATM. Differentiation of 3- hydroxy-3-methylglutaryl coenzyme A reductase inhibitors by their relative lipophilicity. Pharm Pharmacol Commun. 1999;5: 269\u2013271."},{"issue":"2","key":"2506802_CR46","volume":"90","year":"2014","unstructured":"Sokalska A, Stanley SD, Villanueva JA, Ortega I, Duleba AJ. Comparison of effects of different statins on growth and steroidogenesis of rat ovarian theca-interstitial cells. Biol Reprod. 2014;90(2):44.","journal-title":"Biol Reprod"},{"issue":"4","key":"2506802_CR47","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.fertnstert.2005.09.030","volume":"85","author":"AJ Duleba","year":"2006","unstructured":"Duleba AJ, Banaszewska B, Spaczynski RZ, Pawelczyk L. Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial. Fertil Steril. 2006;85(4):996\u20131001.","journal-title":"Fertil Steril"},{"issue":"2","key":"2506802_CR48","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1210\/jc.2006-1988","volume":"92","author":"B Banaszewska","year":"2007","unstructured":"Banaszewska B, Pawelczyk L, Spaczynski RZ, Dziura J, Duleba AJ. Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: prospective, randomized, crossover trial. J Clin Endocrinol Metab. 2007;92(2):456\u2013461.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2506802_CR49","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1210\/jc.2008-1750","volume":"94","author":"T Sathyapalan","year":"2009","unstructured":"Sathyapalan T, Kilpatrick ES, Coady AM, Atkin SL. The effect of atorvastatin in patients with polycystic ovary syndrome: a randomized double-blind placebo-controlled study. J Clin Endocrinol Metab. 2009;94(1):103\u2013108.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2506802_CR50","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1373\/clinchem.2010.144014","volume":"56","author":"T Sathyapalan","year":"2010","unstructured":"Sathyapalan T, Shepherd J, Arnett C, Coady AM, Kilpatrick ES, Atkin SL. Atorvastatin increases 25-hydroxy vitamin D concentrations in patients with polycystic ovary syndrome. Clin Chem. 2010;56(11):1696\u20131700.","journal-title":"Clin Chem"},{"issue":"6","key":"2506802_CR51","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1016\/j.fertnstert.2009.11.045","volume":"94","author":"T Kazerooni","year":"2010","unstructured":"Kazerooni T, Shojaei-Baghini A, Dehbashi S, Asadi N, Ghaffarpasand F, Kazerooni Y. Effects of metformin plus simvastatin on polycystic ovary syndrome: a prospective, randomized, doubleblind, placebo-controlled study. Fertil Steril. 2010;94(6): 2208\u20132213.","journal-title":"Fertil Steril"},{"issue":"6","key":"2506802_CR52","doi-asserted-by":"publisher","first-page":"912","DOI":"10.2310\/JIM.0b013e31821bfd9c","volume":"59","author":"B Rashidi","year":"2011","unstructured":"Rashidi B, Abediasl J, Tehraninejad E, Rahmanpour H, Sills ES. Simvastatin effects on androgens, inflammatory mediators, and endogenous pituitary gonadotropins among patients with PCOS undergoing IVF: results from a prospective, randomized, placebocontrolled clinical trial. J Investig Med. 2011;59(6):912\u2013916.","journal-title":"J Investig Med"},{"issue":"11","key":"2506802_CR53","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3923\/pjbs.2011.658.663","volume":"14","author":"N Navali","year":"2011","unstructured":"Navali N, Pourabolghasem S, Fouladi RF, Nikpour MA. Therapeutic effects of biguanide vs. statin in polycystic ovary syndrome: a randomized clinical trial. Pak J Biol Sci. 2011;14(11): 658\u2013663.","journal-title":"Pak J Biol Sci"},{"issue":"5","key":"2506802_CR54","volume":"95","year":"2011","unstructured":"Raja-Khan N, Kunselman AR, Hogeman CS, Stetter CM, Demers LM, Legro RS. Effects of atorvastatin on vascular function, inflammation, and androgens in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial. Fertil Steril. 2011;95(5):1849\u20131845.","journal-title":"Fertil Steril"},{"issue":"11","key":"2506802_CR55","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1210\/jc.2011-0501","volume":"96","author":"B Banaszewska","year":"2011","unstructured":"Banaszewska B, Pawelczyk L, Spaczynski RZ, Duleba AJ. Effects of simvastatin and metformin on polycystic ovary syndrome after six months of treatment. J Clin Endocrinol Metab. 2011;96(11):3493\u20133501.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2506802_CR56","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.1210\/jc.2012-2279","volume":"97","author":"T Sathyapalan","year":"2012","unstructured":"Sathyapalan T, Shepherd J, Coady AM, Kilpatrick ES, Atkin SL. Atorvastatin reduces malondialdehyde concentrations in patients with polycystic ovary syndrome. J Clin Endocrinol Metab. 2012; 97(11):3951\u20133955.","journal-title":"J Clin Endocrinol Metab"},{"key":"2506802_CR57","first-page":"80","volume-title":"Ann Clin Biochem","author":"T Sathyapalan","year":"2012","unstructured":"Sathyapalan T, Smith KA, Coady AM, Kilpatrick ES, Atkin SL. Atorvastatin therapy decreases androstenedione and dehydroepiandrosterone sulphate concentrations in patients with polycystic ovary syndrome: randomized controlled study. Ann Clin Biochem. 2012;49(pt 1):80\u201385."},{"issue":"12","key":"2506802_CR58","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1210\/jc.2013-2674","volume":"98","author":"J Puurunen","year":"2013","unstructured":"Puurunen J, Piltonen T, Puukka K, et al. Statin therapy worsens insulin sensitivity in women with polycystic ovary syndrome (PCOS): a prospective, randomized, double-blind, placebocontrolled study. J Clin Endocrinol Metab. 2013;98(12): 4798\u20134807.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2506802_CR59","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3109\/09513590.2013.774360","volume":"29","author":"SE Karakas","year":"2013","unstructured":"Karakas SE, Banaszewska B, Spaczynski RZ, Pawelczyk L, Duleba A. Free fatty acid binding protein-4 and retinol binding protein-4 in polycystic ovary syndrome: response to simvastatin and metformin therapies. Gynecol Endocrinol. 2013;29(12): 483\u2013487.","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"2506802_CR60","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s40618-015-0237-3","volume":"38","author":"G Ghazeeri","year":"2015","unstructured":"Ghazeeri G, Abbas HA, Skaff B, Harajly S, Awwad J. Inadequacy of initiating rosuvastatin then metformin on biochemical profile of polycystic ovarian syndrome patients. J Endocrinol Invest. 2015;38(6):643\u201365.","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"2506802_CR61","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1093\/humupd\/7.6.556","volume":"7","author":"YC Cheong","year":"2001","unstructured":"Cheong YC, Laird SM, Li TC, Shelton JB, Ledger WL, Cooke ID. Peritoneal healing and adhesion formation\/reformation. Hum Reprod Update. 2001;7(6):556\u2013566.","journal-title":"Hum Reprod Update"},{"issue":"6","key":"2506802_CR62","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1007\/BF02234701","volume":"44","author":"MC Parker","year":"2001","unstructured":"Parker MC, Ellis H, Moran BJ, et al. Postoperative adhesions: tenyear follow-up of 12,584 patients undergoing lower abdominal surgery. Dis Colon Rectum. 2001;44(6):822\u2013829.","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"2506802_CR63","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/S1091-255X(00)80082-7","volume":"4","author":"AM Ghellai","year":"2000","unstructured":"Ghellai AM, Stucchi AF, Chegini N, et al. Role of transforming growth factor beta-1 in peritonitis-induced adhesions. J Gastrointest Surg. 2000;4(3):316\u2013323.","journal-title":"J Gastrointest Surg"},{"issue":"4","key":"2506802_CR64","volume":"2006","year":"2006","unstructured":"Di Filippo C, Falsetto A, De Pascale V, et al. Plasma levels of t-PA and PAI-1 correlate with the formation of experimental postsurgical peritoneal adhesions. Mediators Inflamm. 2006;2006(4): 13901.","journal-title":"Mediators Inflamm"},{"issue":"2","key":"2506802_CR65","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/01.sla.0000236627.07927.7c","volume":"245","author":"CB Aaron","year":"2007","unstructured":"Aaron CB, Cohen PA, Gower A, et al. Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity. Ann Surg. 2007; 245(2):176\u2013184.","journal-title":"Ann Surg"},{"issue":"3","key":"2506802_CR66","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/bjs.7817","volume":"99","author":"M Lalountas","year":"2012","unstructured":"Lalountas M, Ballas KD, Michalakis A, et al. Postoperative adhesion prevention using a statin-containing cellulose film in an experimental model. Br J Surg. 2012;99(3):423\u2013429.","journal-title":"Br J Surg"},{"issue":"9","key":"2506802_CR67","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ijsu.2013.11.010","volume":"12","author":"E Arslan","year":"2014","unstructured":"Arslan E, Talih T, Oz B, Halaclar B, Caglayan K, Sipahi M. Comparison of lovastatin and hyaluronic acid\/carboxymethyl cellulose on experimental created peritoneal adhesion model in rats. Int J Surg. 2014;12(9):120\u2013124.","journal-title":"Int J Surg"},{"issue":"3","key":"2506802_CR68","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.ygyno.2010.08.017","volume":"119","author":"B Taylor-Harding","year":"2010","unstructured":"Taylor-Harding B, Orsulic S, Karlan BY, Li AJ. Fluvastatin and cisplatin demonstrate synergistic cytotoxicity in epithelial ovarian cancer cells. Gynecol Oncol. 2010;119(3):549\u2013556.","journal-title":"Gynecol Oncol"},{"issue":"12","key":"2506802_CR69","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1111\/j.1349-7006.2008.00977.x","volume":"99","author":"A Horiuchi","year":"2008","unstructured":"Horiuchi A, Kikuchi N, Osada R, et al. Overexpression of RhoA enhances peritoneal dissemination: RhoA suppression with Lovastatin may be useful for ovarian cancer. Cancer Sci. 2008; 99(12):2532\u20132539. Zeybek et al 815","journal-title":"Cancer Sci"},{"issue":"6","key":"2506802_CR70","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00280-008-0830-7","volume":"63","author":"H Liu","year":"2009","unstructured":"Liu H, Liang SL, Kumar S, Weyman CM, Liu W, Zhou A. Statins induce apoptosis in ovarian cancer cells through activation of JNK and enhancement of Bim expression. Cancer Chemother Pharmacol. 2009;63(6):997\u20131005.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"2506802_CR71","first-page":"41","volume":"25","author":"M Matsuura","year":"2011","unstructured":"Matsuura M, Suzuki T, Suzuki M, Tanaka R, Ito E, Saito T. Statin-mediated reduction of osteopontin expression induces apoptosis and cell growth arrest in ovarian clear cell carcinoma. Oncol Rep. 2011;25(1):41\u201347.","journal-title":"Oncol Rep"},{"key":"2506802_CR72","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1471-2407-10-103","volume":"10","author":"A Martirosyan","year":"2010","unstructured":"Martirosyan A, Clendening JW, Goard CA, Penn LZ. Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance. BMC Cancer. 2010;10:103.","journal-title":"BMC Cancer"},{"issue":"2","key":"2506802_CR73","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.ygyno.2014.05.015","volume":"134","author":"MN Schointuch","year":"2014","unstructured":"Schointuch MN, Gilliam TP, Stine JE, et al. Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer. Gynecol Oncol. 2014;134(2):346\u2013355.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"2506802_CR74","doi-asserted-by":"publisher","first-page":"946","DOI":"10.18632\/oncotarget.5834","volume":"7","author":"JE Stine","year":"2016","unstructured":"Stine JE, Guo H, Sheng X, et al. The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and antitumorigenic effects in ovarian cancer. Oncotarget. 2016;7(1): 946\u2013960.","journal-title":"Oncotarget"},{"issue":"5","key":"2506802_CR75","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.cancergen.2015.03.008","volume":"208","author":"H Karlic","year":"2015","unstructured":"Karlic H, Thaler R, Gerner C, et al. Inhibition of the mevalonate pathway affects epigenetic regulation in cancer cells. Cancer Genet. 2015;208(5):241\u2013252.","journal-title":"Cancer Genet"},{"issue":"20","key":"2506802_CR76","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.1158\/1078-0432.CCR-14-3368","volume":"21","author":"Y Kobayashi","year":"2015","unstructured":"Kobayashi Y, Kashima H, Wu RC, et al. Mevalonate pathway antagonist suppresses formation of serous tubal intraepithelial carcinoma and ovarian carcinoma in mouse models. Clin Cancer Res. 2015;21(20):4652\u20134662.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"2506802_CR77","first-page":"1180","volume":"14","author":"S Kato","year":"2010","unstructured":"Kato S, Smalley S, Sadarangani A, et al. Lipophilic but not hydrophilic statins selectively induce cell death in gynaecological cancers expressing high levels of HMGCoA reductase. J Cell Mol Med. 2010;14(5):1180\u20131193.","journal-title":"J Cell Mol Med"},{"issue":"6","key":"2506802_CR78","first-page":"1593","volume":"39","author":"BJ Wagner","year":"2011","unstructured":"Wagner BJ, Lo\u00a8b S, Lindau D, et al. Simvastatin reduces tumor cell adhesion to human peritoneal mesothelial cells by decreased expression of VCAM-1 and b1 integrin. Int J Oncol. 2011;39(6): 1593\u20131600.","journal-title":"Int J Oncol"},{"issue":"1","key":"2506802_CR79","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ygyno.2008.06.007","volume":"111","author":"RG Elmore","year":"2008","unstructured":"Elmore RG, Ioffe Y, Scholes DR, Karlan BY, Li AJ. Impact of statin therapy on survival in epithelial ovarian cancer. Gynecol Oncol. 2008;111(1):102\u2013105.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"2506802_CR80","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ygyno.2013.05.025","volume":"130","author":"O Lavie","year":"2013","unstructured":"Lavie O, Pinchev M, Rennert HS, Segev Y, Rennert G. The effect of statins on risk and survival of gynecological malignancies. Gynecol Oncol. 2013;130(3):615\u2013619.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"2506802_CR81","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/bjc.2014.574","volume":"112","author":"L Baandrup","year":"2015","unstructured":"Baandrup L, Dehlendorff C, Friis S, Olsen JH, Kjaer SK. Statin use and risk for ovarian cancer: a Danish nationwide case-control study. Br J Cancer. 2015;112(1):157\u2013161.","journal-title":"Br J Cancer"},{"issue":"5","key":"2506802_CR82","volume":"8","year":"2013","unstructured":"Fang Z, Tang Y, Fang J, et al. Simvastatin inhibits renal cancer cell growth and metastasis via AKT\/mTOR, ERK and JAK2\/ STAT3 pathway. PloS One. 2013;8(5):e62823.","journal-title":"PloS One"},{"issue":"1","key":"2506802_CR83","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.pharmthera.2006.03.003","volume":"112","author":"Y Shitara","year":"2006","unstructured":"Shitara Y, Sugiyama Y. Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMGCoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions. Pharmacol Ther. 2006;112(1):71\u2013105.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"2506802_CR84","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1124\/jpet.108.146647","volume":"328","author":"T Watanabe","year":"2009","unstructured":"Watanabe T, Kusuhara H, Maeda K, et al. Physiologically based pharmacokinetic modeling to predict transporter-mediated clearance and distribution of pravastatin in humans. J Pharmacol Exp Ther. 2009;328(2):652\u2013662.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1-3","key":"2506802_CR85","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0168-3659(01)00480-1","volume":"78","author":"H Kusuhara","year":"2002","unstructured":"Kusuhara H, Sugiyama Y. Role of transporters in the tissueselective distribution and elimination of drugs: transporters in the liver, small intestine, brain and kidney. J Control Release. 2002;78(1-3):43\u201354.","journal-title":"J Control Release"},{"issue":"1-2","key":"2506802_CR86","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.canlet.2006.01.007","volume":"245","author":"S Hector","year":"2007","unstructured":"Hector S, Nava ME, Clark K, Murphy M, Pendyala L. Characterization of a clonal isolate of an oxaliplatin resistant ovarian carcinoma cell line A2780\/C10. Cancer Lett. 2007;245(1-2): 195\u2013204.","journal-title":"Cancer Lett"},{"issue":"6","key":"2506802_CR87","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2165\/00003088-200039060-00002","volume":"39","author":"T Hatanaka","year":"2000","unstructured":"Hatanaka T. Clinical pharmacokinetics of pravastatin: mechanisms of pharmacokinetic events. Clin Pharmacokinet. 2000; 39(6):397\u2013412.","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"2506802_CR88","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/AOG.0b013e3181e10ebd","volume":"116","author":"MM Costantine","year":"2010","unstructured":"Costantine MM, Tamayo E, Lu F, et al. Using pravastatin to improve the vascular reactivity in a mouse model of soluble fms-like tyrosine kinase-1-induced preeclampsia. Obstet Gynecol. 2010;116(1):114\u2013120.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"2506802_CR89","volume":"209","year":"2013","unstructured":"Nanovskaya TN, Patrikeeva SL, Paul J, Costantine MM, Hankins GD, Ahmed MS. Transplacental transfer and distribution of pravastatin. Am J Obstet Gynecol. 2013;209(4):373.e1-e5.","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"2506802_CR90","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.placenta.2013.05.002","volume":"34","author":"J Zarek","year":"2013","unstructured":"Zarek J, DeGorter MK, Lubetsky A, et al. The transfer of pravastatin in the dually perfused human placenta. Placenta. 2013; 34(8):719\u2013721.","journal-title":"Placenta"},{"issue":"1","key":"2506802_CR91","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1177\/1933719113492207","volume":"21","author":"AF Saad","year":"2014","unstructured":"Saad AF, Kechichian T, Yin H, et al. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia. Reprod Sci. 2014;21(1):138\u2013145.","journal-title":"Reprod Sci"},{"issue":"4","key":"2506802_CR92","volume":"205","year":"2011","unstructured":"Fox KA, Longo M, Tamayo E, et al. Effects of pravastatin on mediators of vascular function in a mouse model of soluble Fmslike tyrosine kinase-1-induced preeclampsia. Am J Obstet Gynecol. 2011;205(4):366.e1-e5.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"2506802_CR93","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nri1839","volume":"6","author":"J Greenwood","year":"2006","unstructured":"Greenwood J, Steinman L, Zamivil SS. Statin therapy and autoimmune disease: from protein prenylation to immunomodulation. Nat Rev Immunol. 2006;6(5):358\u2013370.","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"2506802_CR94","volume":"5","year":"2010","unstructured":"Ahmed A, Singh J, Khan Y, Seshan SV, Girardi G. A new mouse model to explore therapies for preeclampsia. PLoS One. 2010; 5(10):e13663.","journal-title":"PLoS One"},{"issue":"6","key":"2506802_CR95","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1253\/circj.CJ-10-0954","volume":"75","author":"N Ghaffari","year":"2011","unstructured":"Ghaffari N, Ball C, Kennedy JA, Stafford I, Beltrame JF. Acute modulation of vasoconstrictor responses by pravastatin in small vessels. Circ J. 2011;75(6):1506\u20131514.","journal-title":"Circ J"},{"issue":"4","key":"2506802_CR96","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1073\/pnas.1011293108","volume":"108","author":"K Kumasawa","year":"2011","unstructured":"Kumasawa K, Ikawa M, Kidoya H, et al. Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model. Proc Natl Acad Sci USA. 2011;108(4): 1451\u20131455.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2506802_CR97","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1161\/HYPERTENSIONAHA.111.175919","volume":"58","author":"J Singh","year":"2011","unstructured":"Singh J, Ahmed A, Girardi G. Role of complement component C1q in the onset of preeclampsia in mice. Hypertension. 2011; 58(4):716\u2013724.","journal-title":"Hypertension"},{"issue":"5","key":"2506802_CR98","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1161\/HYPERTENSIONAHA.111.00226","volume":"61","author":"AJ Bauer","year":"2013","unstructured":"Bauer AJ, Banek CT, Needham K, et al. Pravastatin attenuates hypertension, oxidative stress, and angiogenic imbalance in rat model of placental ischemia-induced hypertension. Hypertension. 2013;61(5):1103\u20131110.","journal-title":"Hypertension"},{"issue":"11","key":"2506802_CR99","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1177\/1933719116648218","volume":"23","author":"AF Saad","year":"2016","unstructured":"Saad AF, Diken ZM, Kechichian TB, et al. Pravastatin effects on placental prosurvival molecular pathways in a mouse model of preeclampsia. Reprod Sci. 2016;23(11):1593\u20131599.","journal-title":"Reprod Sci"},{"key":"2506802_CR100","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ijdevneu.2013.11.004","volume":"33","author":"AR Carver","year":"2014","unstructured":"Carver AR, Tamayo E, Perez-Polo JR, Saade GR, Hankins GDV, Costantine MM. The effect of maternal pravastatin therapy on adverse sensorimotor outcomes of the offspring in a murine model of preeclampsia. Int J Dev Neurosci. 2014;33:33\u201340.","journal-title":"Int J Dev Neurosci"},{"issue":"6","key":"2506802_CR101","volume":"9","year":"2014","unstructured":"Carver AR, Andrikopoulou M, Lei J, et al. Maternal pravastatin prevents altered fetal brain development in a preeclamptic CD-1 mouse model. PLoS One. 2014;9(6):e100873.","journal-title":"PLoS One"},{"issue":"11","key":"2506802_CR102","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1172\/JCI200318817","volume":"112","author":"G Girardi","year":"2003","unstructured":"Girardi G, Berman J, Redecha P, et al. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest. 2003;112(11):1644\u20131654.","journal-title":"J Clin Invest"},{"issue":"11","key":"2506802_CR103","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1038\/nm1121","volume":"10","author":"G Girardi","year":"2004","unstructured":"Girardi G, Redecha P, Salmon JE. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med. 2004;10(11):1222\u20131226.","journal-title":"Nat Med"},{"issue":"7","key":"2506802_CR104","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1182\/blood-2007-01-070631","volume":"110","author":"P Redecha","year":"2007","unstructured":"Redecha P, Tilley R, Tencati M, et al. Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury. Blood. 2007;110(7):2423\u20132431.","journal-title":"Blood"},{"issue":"10","key":"2506802_CR105","first-page":"3453","volume":"118","author":"P Redecha","year":"2008","unstructured":"Redecha P, Franzke CW, Ruf W, Mackman N, Girardi G. Neutrophil activation by the tissue factor\/Factor VIIa\/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome. J Clin Invest. 2008;118(10):3453\u20133461.","journal-title":"J Clin Invest"},{"issue":"5","key":"2506802_CR106","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/j.1538-7836.2005.01262.x","volume":"3","author":"SS Pierangeli","year":"2005","unstructured":"Pierangeli SS, Ferrara DE. More on: fluvastatin inhibits upregulation of tissue factor expression by antiphospholipid antibodies on endothelial cells. J Thromb Haemost. 2005;3(5): 1112\u20131113.","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2506802_CR107","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0049-3848(03)00346-3","volume":"110","author":"Y Kunieda","year":"2003","unstructured":"Kunieda Y, Nakagawa K, Nishimura H, et al. HMG CoAreductase inhibitor suppresses the expression of tissue factor and plasminogen activator inhibitor-1 induced by angiotensin II in cultured rat aortic endothelial cells. Thromb Res. 2003;110(4):227\u2013234.","journal-title":"Thromb Res"},{"issue":"10","key":"2506802_CR108","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1093\/humrep\/des288","volume":"27","author":"EA Odiari","year":"2012","unstructured":"Odiari EA, Mulla MJ, Sfakianaki AK, et al. Pravastatin does not prevent antiphospholipid antibody-mediated changes in human first trimester trophoblast function. Hum Reprod. 2012;27(10): 2933\u20132940.","journal-title":"Hum Reprod"},{"issue":"8","key":"2506802_CR109","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1172\/JCI86957","volume":"126","author":"E Lefkou","year":"2016","unstructured":"Lefkou E, Mamopoulos A, Dagklis T, Vosnakis C, Rousso D, Girardi G. Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy. J Clin Invest. 2016;126(8):2933\u20132940.","journal-title":"J Clin Invest"},{"issue":"1","key":"2506802_CR110","first-page":"1","volume":"60","author":"JA Martin","year":"2011","unstructured":"Martin JA, Hamilton BE, Ventura SJ, et al. Births: final data for 2009. Natl Vital Stat Rep. 2011;60(1):1\u201370.","journal-title":"Natl Vital Stat Rep"},{"issue":"3","key":"2506802_CR111","volume":"207","year":"2012","unstructured":"Basraon SK, Menon R, Makhlouf M, et al. Can statins reduce the inflammatory response associated with preterm birth in an animal model? Am J Obstet Gynecol. 2012;207(3):224.e1-e7.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"2506802_CR112","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/molehr\/gau019","volume":"20","author":"JM Gonzalez","year":"2014","unstructured":"Gonzalez JM, Pedroni SM, Girardi G. Statins prevent cervical remodeling, myometrial contractions and preterm labor through a mechanism that involves hemoxygenase-1 and complement inhibition. Mol Hum Reprod. 2014;20(6):579\u2013589.","journal-title":"Mol Hum Reprod"},{"issue":"8","key":"2506802_CR113","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.freeradbiomed.2004.11.002","volume":"38","author":"SA Bainbridge","year":"2005","unstructured":"Bainbridge SA, Smith GN. HO in pregnancy. Free Radic Biol Med. 2005;38(8):979\u2013988.","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"2506802_CR114","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1095\/biolreprod.111.098475","volume":"86","author":"M Lappas","year":"2012","unstructured":"Lappas M, Woodruff TM, Taylor SM, Permezel M. Complement C5a regulates prolabor mediators in human placenta. Biol Reprod. 2012;86(6):190\u2013196.","journal-title":"Biol Reprod"},{"issue":"7","key":"2506802_CR115","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1055\/s-0031-1274510","volume":"28","author":"LD Pacheco","year":"2011","unstructured":"Pacheco LD, Hankins GDV, Costantine MM, et al. The role of human decay-accelerating factor in the pathogenesis of preterm Labor. Am J Perinatol. 2011;28(7):565\u2013570.","journal-title":"Am J Perinatol"},{"issue":"1","key":"2506802_CR116","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/aji.12372","volume":"74","author":"SK Basraon","year":"2015","unstructured":"Basraon SK, Costantine MM, Saade G, Menon R. The effect of simvastatin on infection-induced inflammatory response of human fetal membranes. Am J Reprod Immunol. 2015;74(1): 54\u201361.","journal-title":"Am J Reprod Immunol"},{"issue":"7","key":"2506802_CR117","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jsgi.2004.04.001","volume":"11","author":"R Menon","year":"2004","unstructured":"Menon R, Fortunato SJ. The role of matrix degrading enzymes and apoptosis in rupture of membranes. J Soc Gynecol Investig. 2004;11(7):427\u2013437.","journal-title":"J Soc Gynecol Investig"},{"issue":"6","key":"2506802_CR118","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/tera.1420500604","volume":"50","author":"LA Dostal","year":"1994","unstructured":"Dostal LA, Schardein JL, Anderson JA. Developmental toxicity of the HMG-CoA reductase inhibitor, atorvastatin, in rats and rabbits. Teratology. 1994;50(6):387\u2013394.","journal-title":"Teratology"},{"issue":"3","key":"2506802_CR119","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/tera.1420280316","volume":"28","author":"DH Minsker","year":"1983","unstructured":"Minsker DH, MacDonald JS, Robertson RT, Bokelman DL. Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolinic acid, an inhibitor of 3-hydroxy-3- methylglutaryl-coenzyme a reductase. Teratology. 1983;28(3): 449\u2013456.","journal-title":"Teratology"},{"issue":"11","key":"2506802_CR120","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/bdra.20181","volume":"73","author":"PS Pollack","year":"2005","unstructured":"Pollack PS, Shields KE, Burnett DM, Osborne MJ, Cunningham ML, Stepanavage ME. Pregnancy outcomes after maternal exposure to simvastatin and lovastatin. Birth Defects Res A Clin Mol Teratol. 2005;73(11):888\u2013896.","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"4","key":"2506802_CR121","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/j.1365-2125.2007.02905.x","volume":"64","author":"B Ofori","year":"2007","unstructured":"Ofori B, Ray E, Berard A. Risk of congenital anomalies in pregnant users of statin drugs. Br J Clin Pharmacol. 2007; 64(4):496\u2013509.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"2506802_CR122","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1586\/erc.11.196","volume":"10","author":"DM Kusters","year":"2012","unstructured":"Kusters DM, Lahsinoui HH, van de Post JAM, et al. Statin use during pregnancy: a systematic review and meta-analysis. Expert Rev Cardiovasc Ther. 2012;10(3):363\u2013378.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"2","key":"2506802_CR123","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.reprotox.2008.06.009","volume":"26","author":"N Taguchi","year":"2008","unstructured":"Taguchi N, Rubin ET, Hosokawa A, et al. Prenatal exposure to HMG-CoA reductase inhibitors: effects on fetal and neonatal outcomes. Reprod Toxicol. 2008;26(2):175\u2013177.","journal-title":"Reprod Toxicol"},{"issue":"4","key":"2506802_CR124","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/1471-0528.12066","volume":"120","author":"U Winterfield","year":"2013","unstructured":"Winterfield U, Allignol A, Panchaud A, et al. Pregnancy outcome following maternal exposure to statins: a multicenter prospective study. BJOG. 2013;120(4):463\u2013471.","journal-title":"BJOG"},{"key":"2506802_CR125","volume-title":"Br Med J","author":"BT Bateman","year":"2015","unstructured":"Bateman BT, Hernandez-Diaz S, Fischer MA, et al. Statins and congenital malformations: cohort study. Br Med J. 2015;350: h1035."},{"issue":"7560","key":"2506802_CR126","volume":"333","year":"2006","unstructured":"Macintosh MC, Fleming KM, Bailey JA, et al. Perinatal mortality and congenital anomalies in babies of women with Type 1 or Type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ. 2006;333(7560):177.","journal-title":"BMJ"},{"issue":"3","key":"2506802_CR127","volume":"120","year":"2008","unstructured":"Satpathy HK, Fleming A, Frey D, Barsoom M, Satpathy C, Khandalavala J. Maternal obesity and pregnancy. Postgrad Med. 2008;120(3):E01-E09.","journal-title":"Postgrad Med"},{"issue":"5","key":"2506802_CR128","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.jacl.2016.07.002","volume":"10","author":"DG Karalis","year":"2016","unstructured":"Karalis DG, Hill AN, Clifton S, Wild RA. The risks of statin use in pregnancy: a systematic review. J Clin Lipidol. 2016;10(5): 1081\u20131090.","journal-title":"J Clin Lipidol"},{"issue":"6","key":"2506802_CR129","volume":"210","year":"2014","unstructured":"McDonnold M, Tamayo E, Kechichian T, et al. The effect of prenatal pravastatin treatment on altered fetal programming of postnatal growth and metabolic function in a preeclampsia-like murine model. Am J Obstet Gynecol. 2014;210(6):542.e1-e7.","journal-title":"Am J Obstet Gynecol"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719117750751.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1933719117750751","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1177\/1933719117750751\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1933719117750751","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719117750751.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T22:06:30Z","timestamp":1656799590000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1177\/1933719117750751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":129,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["2506802"],"URL":"https:\/\/doi.org\/10.1177\/1933719117750751","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"1 June 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}